Patent · US Active

Compounds, compositions and methods

US10385023B2 · kind B2 · utility

21Cited by
50References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2018
Grant dateAug 20, 2019
Priority date—
Expiry dateJun 28, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.